Dr. Murray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 E 41st St
New York, NY 10017Phone+1 646-825-6300
Summary
- Dr. Katie Murray is a urological oncologist in New York, NY. She serves as Associate Professor of Urology at New York University Langone and Chief of Urology at Bellevue Hospital. She received her medical degree from A. T. Still University Kirksville College of Osteopathic Medicine, followed by residency in Urology at the University of Kansas and fellowship at Memorial Sloan Kettering Cancer Center. She has been in practice since 2016. She has more than 70 publications and over 400 citings.
Education & Training
- University of MissouriMS, 2017 - 2018
- Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2014 - 2016
- University of Kansas School of MedicineResidency, Urology, 2009 - 2014
- University of Missouri-Kansas City School of MedicineInternship, Transitional Year, 2009 - 2010
- A. T. Still University Kirksville College of Osteopathic MedicineClass of 2009
- Westminster College - MissouriB.A., Biology, Summa cum Laude, 2001 - 2005
- University of MissouriNo degree
Certifications & Licensure
- NY State License 2014 - 2026
- MO State License 2016 - 2025
- KS State License Active through 2014
- American Board of Urology Urology
Awards, Honors, & Recognition
- Urology Case Reports Top Article Winner 2018
- Guardian Angel Recipient MU Health Care, 2018
- Outstanding Reviewer: Urologic Oncology Seminars and Original Investigations 2018
- Join now to see all
Clinical Trials
- Perioperative Pregabalin in Ureteroscopy Start of enrollment: 2020 Jun 01
Publications & Presentations
PubMed
- 67 citationsEffect of COVID-19 on Urology Residency Training: A Nationwide Survey of Program Directors by the Society of Academic Urologists.Geoffrey H. Rosen, Katie S. Murray, Kirsten Greene, Raj S. Pruthi, Lee Richstone
The Journal of Urology. 2020-05-28 - 35 citationsIntravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized TrialMassimiliano Spaliviero, Nicholas Power, Katie S. Murray, Daniel Sjöberg, Nicole Benfante
European Urology. 2018-01-01 - 2 citationsPhase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr OutcomesNathan C. Wong, Ricardo Alvim, Daniel Sjöberg, Roman Shingarev, Nicholas Power
European Urology Focus. 2019-04-25
Journal Articles
- Li-Fraumeni Syndrome-Related Malignancies Involving the Genitourinary Tract: A Case Report and Review of a Single-Institution ExperienceMurray KS, Spaliviero M, Tonorezos ES, Lacouture ME, Tap WD, Oeffinger KC, Vargas HA, and Eastham JA, Urology, 1/1/2018
- Female Representation on Journal Editorial Boards: Is Urology Behind the Times?Henderson AA, Ahmed H, and Murray, J Urol, 1/1/2018
- Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer XenograftsKim K, Watson PA, Lebdai S, Jebiwott S, Somma AJ, LaRosa S, Mehta D, Murray KS, Lilja H, Ulmert D, Monette S, Scherz A, and Coleman JA, Clin Cancer Res, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Intraoperative Identification of Nerves with an Intravenous Nerve-Binding Fluorophore: Subjective and Objective Assessment of Fluorescence in Porcine ModelsDean LW, Recabal P, Dylov DV, Hehir CT, Bagrodia A, Murray KS, Sequeira S, Levine E, Ouerfelli O, Coleman JA, Scardino PT, Laudone VP, and Donahue TF, J Urol, 1/1/2018
- Phase 3 Randomised Trial of Intravenous Mannitol Versus Placebo Prior to Renal Ischemia During Nephron-Sparing Surgery: Impact on Renal Functional OutcomesSpaliviero M, Power NE, Murray KS, Sjoberg DD, Benfante NE, Bernstein ML, Wren JD, Russo P, and Coleman JA, J Urol, 1/1/2017
- Partial Nephrectomy in the Treatment of Renal Tumors with Concomitant Venous Tumor Thrombosis (VTT) of Renal Vein Branches: Retrospective, Multi-Center Analysis of Per...Zattoni F, Thompson RH, Capitano U, Crestani A, Ficarra V, Kutikov A, Larcher A, Lane BR, Leibovich BC, McIntosh A, Montorsi F, Moon D, Muilwijk T, Murray K, Noyes S, ..., J Urol, 1/1/2017
- Join now to see all
Lectures
- Robotics in Urological SurgeryLake Ozark, MO - 1/1/2018
- PSA and Prostate Cancer: First, Do No HarmColumbia, MO - 1/1/2017
- Testosterone Replacement Therapy: Who Should Be Doing and with What?St Charles, MO - 1/1/2017
- Join now to see all
Press Mentions
- Treatment of Unfavorable Intermediate Risk Prostate Cancer - Ashley Ross, Jason Hafron, and Katie MurrayJune 14th, 2022
- Parkview Relocating Shot SiteJune 25th, 2021
- Health Group Starts Mobile ServiceJune 16th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: